502 related articles for article (PubMed ID: 19372946)
1. Treatment of acute HIV-1 infection: are we getting there?
Cellerai C; Little SJ; Loes SK
Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
[TBL] [Abstract][Full Text] [Related]
2. Role of the gastrointestinal tract in establishing infection in primates and humans.
Mehandru S; Dandekar S
Curr Opin HIV AIDS; 2008 Jan; 3(1):22-7. PubMed ID: 19372940
[TBL] [Abstract][Full Text] [Related]
3. Latent HIV-1 reservoirs in children: considerations for therapy.
Persaud D
Curr Opin HIV AIDS; 2006 Mar; 1(2):174-8. PubMed ID: 19372804
[TBL] [Abstract][Full Text] [Related]
4. Viral reservoirs and HIV-specific immunity.
Blankson JN
Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
[TBL] [Abstract][Full Text] [Related]
5. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic immunization in HIV infection.
Autran B; Kinloch-de Loes S; Katlama C
Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
[TBL] [Abstract][Full Text] [Related]
7. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
Lederman MM; Penn-Nicholson A; Stone SF; Sieg SF; Rodriguez B
Curr Opin HIV AIDS; 2007 Jan; 2(1):56-61. PubMed ID: 19372866
[TBL] [Abstract][Full Text] [Related]
8. Virological rebound and its consequences during treatment interruption.
van Lunzen J; Hoffmann C
Curr Opin HIV AIDS; 2007 Jan; 2(1):1-5. PubMed ID: 19372858
[TBL] [Abstract][Full Text] [Related]
9. HIV vaccines: can mucosal CD4 T cells be protected?
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
[TBL] [Abstract][Full Text] [Related]
10. Animal models of HIV-1 latency and persistence.
Brown HJ; Zack JA
Curr Opin HIV AIDS; 2006 Mar; 1(2):103-7. PubMed ID: 19372792
[TBL] [Abstract][Full Text] [Related]
11. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
12. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
13. Attacking latent HIV provirus: from mechanism to therapeutic strategies.
Archin NM; Margolis DM
Curr Opin HIV AIDS; 2006 Mar; 1(2):134-40. PubMed ID: 19372797
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy in coinfected patients: viral hepatitis and tuberculosis.
Rockstroh JK; Hardy WD
Curr Opin HIV AIDS; 2006 Sep; 1(5):442-8. PubMed ID: 19372845
[TBL] [Abstract][Full Text] [Related]
15. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials.
Haggerty CM; Pitt E; Siliciano RF
Curr Opin HIV AIDS; 2006 Jan; 1(1):62-8. PubMed ID: 19372786
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of primary HIV-1 infection.
Gelgor L; Kaldor J
Curr Opin HIV AIDS; 2008 Jan; 3(1):4-9. PubMed ID: 19372937
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and residual HIV infection.
Crowe SM
Curr Opin HIV AIDS; 2006 Mar; 1(2):129-33. PubMed ID: 19372796
[TBL] [Abstract][Full Text] [Related]
19. Dynamic characteristics of HIV-1 reservoirs.
Kim H; Perelson AS
Curr Opin HIV AIDS; 2006 Mar; 1(2):152-6. PubMed ID: 19372800
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapies.
Chomont N; Trautmann L; Routy JP; Sékaly RP
Curr Opin HIV AIDS; 2007 Mar; 2(2):116-22. PubMed ID: 19372876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
